AGT and metabolic dysfunction-associated steatotic liver disease: These findings indicate that liraglutide plays a dual regulatory role on the two axes of the RAS; (4) the RAS axis could be reversed following treatment with A779 or AngII, which attenuated or even blocked liraglutide-mediated improvement of NAFLD.